title: Patients developing anti-Epo antibodies during rHuEpo treatment do not express a polymorphic variant of Epo.
authors.forename: Zahra
authors.initials: Z
authors.lastname: Kadri
authors.forename: Patrick
authors.initials: P
authors.lastname: Mayeux
authors.forename: Nicole
authors.initials: N
authors.lastname: Casadevall
authors.forename: Stany
authors.initials: S
authors.lastname: Chretien
mesh_terms: D000740:Anemia / Q000188:drug therapy*; D000906:Antibodies / Q000097:blood; D004921:Erythropoietin / Q000235:genetics* / Q000276:immunology* / Q000627:therapeutic use; D006801:Humans; D011110:Polymorphism, Genetic; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000235:genetics* / Q000276:immunology*
chemical_list: D000906:Antibodies; D011994:Recombinant Proteins; D004921:Erythropoietin